Unknown

Dataset Information

Efficacy of probiotics as adjuvant therapy in bronchial asthma: a systematic review and meta-analysis.


ABSTRACT:

Background

Asthma is a chronic, heterogeneous disease characterized by airway inflammation. Asthma exacerbations significantly increase the disease burden, necessitating new therapeutic approaches. Emerging evidence suggests probiotics, through the gut-lung axis, may benefit asthma management by modulating immune responses and reducing inflammation.

Methods

This systematic review and meta-analysis adhered to PRISMA guidelines and was registered with PROSPERO (CRD42023480098). A comprehensive search of PubMed, Scopus, Web of Science, and Embase was conducted up to March 2024. Inclusion criteria encompassed randomized controlled trials (RCTs) evaluating probiotic interventions in asthma patients. Statistical analysis was done using RevMan 5.3, with odds ratios (OR) and 95% con

SUBMITTER: Balan D 

PROVIDER: S-EPMC11575415 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature